This could be due to a variety of reasons such as genetic factors, underlying health conditions like pernicious anaemia, or gastrointestinal surgery
however, all patients should avoid drugs that impair clotting (NHLBI 2012)
They happen with both semaglutide and tirzepatide, typically after 3-6 months of treatment when the body adapts to the current dose level and weight loss slows or stops
This bypasses the digestive system, potentially enhancing bioavailability and minimizing the risk of stomach upset or digestive problems. But do they actually work
The study, International coverage of GLP-1 Receptor Agonists: A Review and Ethical Analysis of Discordant Approaches, was published on August 16, 2024 in the Lancet
Third-party HPLC validated to 99%+ purity